Remote central effects of botulinum toxin type A as adjuvant to intense occupational therapy in the early stage of stroke: A Type II fMRI randomised controlled trial

Occupational Therapy ◽

Early Stage ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Botulinum Toxin Type ◽

Type Ii ◽

Central Effects ◽

271 A randomised controlled trial to evaluate the efficacy of botulinum toxin type A in the treatment of patients suffering bladder pain syndrome/interstitial cystitis with Hunner's lesions: Preliminary results

European Urology Supplements ◽

10.1016/s1569-9056(12)60268-1 ◽

2012 ◽

Vol 11 (1) ◽

pp. e271-e271a ◽

Cited By ~ 1

Author(s):

A.V. Zaitcev ◽

G.R. Kasyan ◽

O. Tsibulya ◽

D.Y. Pushkar

Keyword(s):

Botulinum Toxin ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Pain Syndrome ◽

Botulinum Toxin Type ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Clinical Governance An International Journal ◽

10.1108/cgij.2010.24815dae.002 ◽

2010 ◽

Vol 15 (4) ◽

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Upper Limb ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Clinical Effectiveness ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Trials ◽

10.1186/1745-6215-9-59 ◽

2008 ◽

Vol 9 (1) ◽

Cited By ~ 11

Author(s):

Helen Rodgers ◽

◽

Lisa Shaw ◽

Christopher Price ◽

Frederike van Wijck ◽

...

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Clinical Effect ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

Randomised Controlled ◽

Design And Methods

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Health Technology Assessment ◽

10.3310/hta14260 ◽

2010 ◽

Vol 14 (26) ◽

Cited By ~ 92

Author(s):

L Shaw ◽

H Rodgers, ◽

C Price ◽

F van Wijck ◽

P Shackley ◽

...

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Upper Limb ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Clinical Effectiveness ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

A pragmatic, unblinded randomised controlled trial comparing an occupational therapy-led lifestyle approach and routine GP care for panic disorder treatment in primary care

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70815-6 ◽

2008 ◽

Vol 2008 ◽

pp. 237-238

Author(s):

J.C. Ballenger

Keyword(s):

Primary Care ◽

Panic Disorder ◽

Occupational Therapy ◽

Controlled Trial ◽

Disorder Treatment ◽

Randomised Controlled ◽

Gp Care

Faculty Opinions recommendation of Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160807.628059 ◽

2009 ◽

Author(s):

Babak Sarani

Keyword(s):

Occupational Therapy ◽

Critically Ill ◽

Critically Ill Patients ◽

Controlled Trial ◽

Mechanically Ventilated ◽

Faculty Opinions recommendation of Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962357.793466005 ◽

2012 ◽

Author(s):

Arun Bhaskar

Keyword(s):

Botulinum Toxin ◽

Shoulder Pain ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725299667.793502852 ◽

2015 ◽

Author(s):

Mark Obermann ◽

Dagny Holle

Keyword(s):

Botulinum Toxin ◽

Trigeminal Neuralgia ◽

Therapeutic Effect ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Double Blind Placebo

Effect of botulinum toxin type A for treating hypertrophic scars: A split‐scar, double‐blind randomized controlled trial

Journal of Cosmetic Dermatology ◽

10.1111/jocd.13627 ◽

2020 ◽

Vol 19 (9) ◽

pp. 2252-2258

Author(s):

Ahmad R. Elshahed ◽

Khaled S. Elmanzalawy ◽

Hany Shehata ◽

Mohamed L. ElSaie

Keyword(s):

Randomized Controlled Trial ◽

Botulinum Toxin ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Hypertrophic Scars ◽

Double Blind ◽

Randomized Controlled

822 RANDOMIZED CONTROLLED TRIAL FOR EFFICACY OF BOTULINUM TOXIN TYPE A IN TREATMENT OF PATIENTS SUFFERING BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS WITH HUNNERS' LESIONS PRELIMINARY RESULTS

The Journal of Urology ◽

10.1016/j.juro.2012.02.912 ◽

2012 ◽

Vol 187 (4S) ◽

Cited By ~ 9

Author(s):

George Kasyan ◽

Dmitry Pushkar

Keyword(s):

Randomized Controlled Trial ◽

Botulinum Toxin ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Pain Syndrome ◽

Botulinum Toxin Type ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomized Controlled